scholarly journals Spontaneous regression of biopsy proven primary renal cell carcinoma: A case study

2012 ◽  
Vol 6 (5) ◽  
pp. E203-E205 ◽  
Author(s):  
Gurswinder Gary Jawanda ◽  
Darrel Drachenberg
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Spontaneous Regression ◽  
Primary Renal Cell Carcinoma

scholarly journals Spontaneous regression of biopsy proven primary renal cell carcinoma: A case study

2012 ◽  
Vol 6 (5) ◽  
Author(s):  
Gurswinder Gary Jawanda ◽  
Darrel Drachenberg
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Complete Resolution ◽  
Spontaneous Regression ◽  
Interesting Phenomenon ◽  
Primary Renal Cell Carcinoma

Spontaneous regression of renal cell carcinoma (RCC) is a wellrecognized and interesting phenomenon that is poorly understood and rarely documented. There are very few reported cases of spontaneously regressed primary RCC. We present a 63-year-old male with a biopsy-proven RCC that regressed with complete resolution of symptoms.

Spontaneous Regression of Primary Renal Cell Carcinoma - A Case Report -

1986 ◽  
Vol 27 (4) ◽  
pp. 314 ◽  
Author(s):  
Seung Kang Choi ◽  
Soo Kee Chang ◽  
Jin Moo Lee ◽  
Woo Hee Jung ◽  
Chan Il Park
Keyword(s):  
Renal Cell Carcinoma ◽  
Case Report ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Spontaneous Regression ◽  
Primary Renal Cell Carcinoma

SPONTANEOUS REGRESSION OF PRIMARY RENAL CELL CARCINOMA WITH INFERIOR VENA CAVAL TUMOR THROMBUS

2002 ◽  
Vol 167 (1) ◽  
pp. 242-243 ◽  
Author(s):  
K.O. KOBAYASHI ◽  
TAKASHI SATO ◽  
KEN-ICHI SUNAOSHI ◽  
ATSUSHI TAKAHASHI ◽  
MITSUHARU TAMAKAWA
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Spontaneous Regression ◽  
Inferior Vena ◽  
Inferior Vena Caval ◽  
Primary Renal Cell Carcinoma ◽  
Caval Tumor Thrombus

502: Effect of Sunitinib in Patients with Unresectable Primary Renal Cell Carcinoma

2007 ◽  
Vol 177 (4S) ◽  
pp. 167-168 ◽  
Author(s):  
Anil Thomas ◽  
Brian R. Lane ◽  
Brian I. Rini ◽  
Steven C. Campbell
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Primary Renal Cell Carcinoma

An Atypical Case of Renal Mass - A Case Study

2020 ◽  
Vol 15 (2) ◽  
pp. 56-58
Author(s):  
Shafiqur Rahman ◽  
B Ahmed ◽  
ATM Mowladad Chowdhury ◽  
Mirza M Hasan ◽  
Sayedul Islam
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Clinical Diagnosis ◽  
Renal Cell ◽  
Renal Mass ◽  
Clinical Presentation ◽  
Atypical Case ◽  
Renal Tuberculosis

A forty eight year old woman with the clinical diagnosis of renal mass due to renal cell carcinoma was found to have renal tuberculosis. The clinical presentation and management are being discussed. Bangladesh Journal of Urology, Vol. 15, No. 2, July 2012 p.56-58

Adult Xp11.2 translocation renal cell carcinoma managed effectively with pazopanib

2021 ◽  
Vol 14 (6) ◽  
pp. e243058
Author(s):  
Cristian Solano ◽  
Shrinjaya Thapa ◽  
Mohammad Muhsin Chisti
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Stable Disease ◽  
Renal Cell ◽  
Systemic Treatment ◽  
Pulmonary Nodules ◽  
Progression Of Disease ◽  
Xp11.2 Translocation ◽  
Adrenal Nodule

Xp11.2 translocation renal cell carcinoma (TRCC) is a rare and aggressive variant of renal cell carcinoma (RCC) when presenting in adults. We report a case of a man in his early 40s who was diagnosed with stage III Xp11.2 TRCC and underwent radical nephrectomy. Seven months following the surgery, an adrenal nodule and bilateral pulmonary nodules were discovered. He underwent cryoablation of the adrenal nodule and systemic treatment with daily pazopanib. He displayed stable disease for approximately 6 years. Following this period, multiple hospitalisations interrupted daily pazopanib therapy resulting in progression of disease. His regimen was then changed to ipilimumab and nivolumab, followed by current daily therapy with axitinib. The patient now shows stable disease in his 10th year after diagnosis. This case study demonstrates the efficacy of pazopanib for metastatic Xp11.2 TRCC and warrants further investigation to supplement the guidelines regarding the use of targeted therapy for TRCC.

Sign in / Sign up

Export Citation Format

Share Document